6,531 followers
New research: A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer: Background Anlotinib is a novel oral small-molecule tyrosine kinase inhibitor (TKI),… https://t.co/8x